Aliases & Classifications for Bronchiectasis

About this section

Aliases & Descriptions for Bronchiectasis:

Name: Bronchiectasis 11 50 39 13 68
Polynesian Bronchiectasis 11
 
Kartagener Syndrome 68

Classifications:



External Ids:

Disease Ontology11 DOID:9563
ICD1030 J47, J47.9
ICD9CM32 494
MeSH39 D001987
NCIt45 C84475

Summaries for Bronchiectasis

About this section
Disease Ontology:11 A bronchial disease that is a chronic inflammatory condition of one or more bronchi or bronchioles marked by dilatation and loss of elasticity of the walls resulting from damage to the airway wall leading to the formation of small sacs on the bronchial wall and impairment of cilia mobility in the lung. Inflammation of the bronchial wall increases mucus secretion which serves as a breeding ground for bacteria. Bronchiectasis is caused by repeated respiratory infections, immune deficiency disorders, hereditary disorders (cystic fibrosis or primary ciliary dyskinesia), mechanical factors (inhaled object or a lung tumor) or inhaling toxic substances.

MalaCards based summary: Bronchiectasis, also known as polynesian bronchiectasis, is related to bronchiectasis with or without elevated sweat chloride 1 and bronchiectasis with or without elevated sweat chloride 2, and has symptoms including anosmia and headache. An important gene associated with Bronchiectasis is DNAI1 (Dynein Axonemal Intermediate Chain 1). The drug acetylcysteine has been mentioned in the context of this disorder. Affiliated tissues include lung, neutrophil and heart, and related mouse phenotype respiratory system.

Wikipedia:71 Bronchiectasis is a disease in which there is permanent enlargement of parts of the airways of the lung.... more...

Related Diseases for Bronchiectasis

About this section

Diseases related to Bronchiectasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 172)
idRelated DiseaseScoreTop Affiliating Genes
1bronchiectasis with or without elevated sweat chloride 112.1
2bronchiectasis with or without elevated sweat chloride 212.1
3bronchiectasis with or without elevated sweat chloride 312.1
4idiopathic bronchiectasis12.1
5ciliary dyskinesia-bronchiectasis11.9
6bronchiectasis oligospermia11.7
7kartagener syndrome11.6
8ciliary dyskinesia, primary, 1, with or without situs inversus11.4
9cystic fibrosis11.2
10primary ciliary dyskinesia11.1
11yellow nail syndrome11.0
12tracheobronchomegaly10.9
13ciliary dyskinesia, primary, 3210.8
14ciliary dyskinesia, primary, 2810.8
15ciliary dyskinesia, primary, 2710.8
16ciliary dyskinesia, primary, 2510.8
17ciliary dyskinesia, primary, 2610.8
18ciliary dyskinesia, primary, 2210.7
19ciliary dyskinesia, primary, 1210.7
20ciliary dyskinesia, primary, 1110.7
21cutis laxa, ad10.7
22ciliary dyskinesia, primary, 2310.7
23ciliary dyskinesia, primary, 3010.7
24ciliary dyskinesia, primary, 9, with or without situs inversus10.7
25neonatal candidiasis10.7DNAH5, DNAI1
26immunodeficiency 1410.6
27ciliary dyskinesia, primary, 2110.6
28ciliary dyskinesia, primary, 1410.6
29ciliary dyskinesia, primary, 2910.6
30panbronchiolitis, diffuse10.6
31ciliary dyskinesia, primary, 1810.6
32ciliary dyskinesia, primary, 610.6
33ciliary dyskinesia, primary, 1910.6
34cutis laxa, autosomal dominant 310.6
35nephronophthisis 1510.6
36ciliary dyskinesia, primary, 1010.6
37ciliary dyskinesia, primary, 1610.6
38cutis laxa, autosomal dominant 210.6
39ciliary dyskinesia, primary, 510.6
40ciliary dyskinesia, primary, 1310.6
41ciliary dyskinesia, primary, 1710.6
42ciliary dyskinesia, primary, 1510.6
43immunodeficiency 1210.6
44ciliary dyskinesia, primary, 2010.6
45ciliary dyskinesia, primary, 210.6
46ciliary dyskinesia, primary, 2410.6
47ciliary dyskinesia, primary, 3, with or without situs inversus10.6
48ciliary dyskinesia, primary, 7, with or without situs inversus10.6
49primary ciliary dyskinesia 3410.6
50primary ciliary dyskinesia 3310.6

Comorbidity relations with Bronchiectasis via Phenotypic Disease Network (PDN):


Rheumatoid ArthritisOsteoporosis
AspergillosisDeficiency Anemia
Familial Atrial FibrillationLung Abscess
Respiratory FailureHeart Disease
Protein-Energy MalnutritionEsophagitis
Postinflammatory Pulmonary FibrosisChronic Pulmonary Heart Disease
BronchopneumoniaHypothyroidism
Anxiety DisorderIdiopathic Interstitial Pneumonia
Pulmonary TuberculosisMitral Valve Disease
BronchitisPrimary Agammaglobulinemia

Graphical network of the top 20 diseases related to Bronchiectasis:



Diseases related to bronchiectasis

Symptoms & Phenotypes for Bronchiectasis

About this section

UMLS symptoms related to Bronchiectasis:


anosmia, headache

MGI Mouse Phenotypes related to Bronchiectasis according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000538810.3ARMC4, DNAAF2, DNAAF3, DNAH5, DNAI1, DRC1

Drugs & Therapeutics for Bronchiectasis

About this section

Drugs for Bronchiectasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 163)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Tobramycinapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 111832986-56-45496, 36294
Synonyms:
1-Epitobramycin
11098-01-4
11111-45-8
3'-Deoxykanamycin B
3'-Deoxykanamycin b
32986-56-4
34337-51-4
37321-13-4
49842-07-1 (Sulfate)
54330-95-9
70322-33-7
79645-27-5
A 12253A
AB00513858
AC1L1KGY
AC1L1VI0
AC1O7GFJ
AC1Q2AOW
AKOS000715235
Aktob
BAS 00463364
BIDD:GT0503
BPBio1_000647
BRN 1357507
BSPBio_000587
BSPBio_002036
Brulamycin
C00397
C18H37N5O9
CAS-32986-56-4
CHEBI:28864
CHEBI:533587
CHEMBL1747
CID11340303
CID36294
CID5496
CID6604388
CID9804613
CID9934285
CPD000058793
D00063
DB00684
Deoxykanamycin B
Distobram
EINECS 251-322-5
Gotabiotic
HMS1569N09
HMS2090B16
HMS2092M17
HSDB 3259
KBio2_001552
KBio2_004120
KBio2_006688
KBio3_001536
KBioGR_001104
KBioSS_001552
LS-146940
LS-187329
Lilly 47663
MLS000069544
MolPort-001-934-131
MolPort-003-665-548
MolPort-003-939-629
NCGC00016814-01
NCGC00178852-01
NCGC00178852-02
NEBRAMYCIN
NF 6
NSC 180514
 
NSC180514
Nebcin
Nebcin (Sulfate)
Nebicin
Nebramycin 6
Nebramycin VI
Nebramycin factir 6
Nebramycin factor 6
Nebramycin-Faktor 6
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine
Obracin
Obramycin
Prestwick0_000544
Prestwick1_000544
Prestwick2_000544
Prestwick3_000544
Prestwick_850
S2514_Selleck
SAM001246911
SMR000058793
SPBio_000295
SPBio_002508
SPECTRUM1500579
SPRC-AB01
STK182610
Spectrum2_000078
Spectrum3_000588
Spectrum4_000752
Spectrum5_001038
Spectrum_001072
Sybryx
T4014_SIGMA
TOA-(1-6)2TB-(4-1)TOC
TOA-(1-6)TOB-(4-1)TOC
TOBRAMYCIN SULFATE
TOY
Tenebrimycin
Tenemycin
Tobacin
Tobi
Tobracin
Tobracin (TN)
Tobracin (tn)
Tobradex
Tobradistin
Tobralex
Tobramaxin
Tobramicin
Tobramicina
Tobramicina [INN-Spanish]
Tobramitsetin
Tobramycetin
Tobramycin
Tobramycin (JP15/USP)
Tobramycin Sulfate
Tobramycin [USAN:BAN:INN:JAN]
Tobramycin for Inhalation
Tobramycin solution for inhalation
Tobramycin, Free Base
Tobramycine
Tobramycine [INN-French]
Tobramycinum
Tobramycinum [INN-Latin]
Tobrased
Tobrasone
Tobrex
Tobrex (TN)
Tobrex (tn)
UNII-VZ8RRZ51VK
tobramycin
tobramycin solution for inhalation
2
AzithromycinapprovedPhase 4, Phase 3, Phase 2, Phase 133383905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
3
TheophyllineapprovedPhase 46258-55-92153
Synonyms:
1,3 Dimethylxanthine
1,3-Dimethylxanthine
1,3-dimethyl-7H-purine-2,6-dione
1,3-dimethylxanthine
111079-49-3
1H-purine-2,6-dione
2a3a
46157-00-0
56645-32-0
58-55-9
75448-53-2
AB00052106
AC-20328
AC1L1D1F
AI3-50216
AKOS000120961
Accurbron
Acet-theocin
Aerobin
Aerolate
Aerolate III
Aerolate SR
Afonilm
Afonilum
Afonilum Retard
Aminophylline
Aquaphyllin
Armophylline
Asbron
Asmalix
Asmax
Austyn
BCBcMAP01_000071
BIDD:ER0557
BIDD:GT0151
BPBio1_000791
BPBio1_001041
BSPBio_000719
BSPBio_000945
BSPBio_002363
Bilordyl
Bronchodid Duracap
Bronchoparat
Bronchoretard
Bronkodyl
Bronkodyl SR
Bronkotabs
C07130
C7H8N4O2
CCRIS 4729
CHEBI:28177
CHEMBL190
CID2153
CPD-12479
CPD000058537
Cetraphylline
Choledyl SA
Chronophyllin
Constant T
Constant-T
ConstantT
D00371
D013806
DB00277
Diffumal
Dimethylxanthine
Diphyllin
DivK1c_000203
Doraphyllin
Duraphyl
Duraphyllin
Dyspne-Inhal
EINECS 200-385-7
Egifilin
Elixex
Elixicon
Elixomin
Elixophyllin
Elixophyllin (TN)
Elixophyllin SR
Elixophyllin(e)
Elixophylline
Etheophyl
Euphylline
Euphylong
GS 2591A
HMS1921E03
HMS2089A06
HMS2092M05
HMS500K05
HSDB 3399
Hylate
IDI1_000203
KBio1_000203
KBio2_001518
KBio2_004086
KBio2_006654
KBio3_001583
KBioGR_000785
KBioSS_001518
L000595
LASMA
LS-241
LaBID
Labid
Labophylline
Lanophyllin
Liquophylline
Liquorice
Lopac0_000014
MLS000069390
MLS002152943
MLS002153487
Maphylline
Medaphyllin
MolPort-001-002-058
MolPort-001-737-342
Mudrane
NCGC00018117-01
NCGC00018117-16
NCGC00022112-03
NCGC00022112-04
NCGC00022112-05
NCGC00022112-07
NCGC00022112-08
NCGC00022112-09
NCGC00022112-10
NCGC00022112-11
NCI60_001736
NINDS_000203
NSC 2066
NSC2066
Nuelin
Nuelin S.A
Nuelin S.A.
Nuelin SA
Optiphyllin
PDSP1_001018
PDSP1_001234
PDSP2_001002
PDSP2_001218
Parkophyllin
Physpan
Prestwick0_000820
Prestwick0_000873
Prestwick1_000820
Prestwick1_000873
Prestwick2_000820
Prestwick2_000873
Prestwick3_000820
Prestwick3_000873
Pro-vent
Pseudotheophylline
 
Pulmidur
Pulmo-Timelets
Quibron
Quibron T
Quibron T SR
Quibron T-SR
Quibron T/SR
Quibron TSR
Quibron-T
Quibron-T/SR
Quibron-T/Sr
Quibron-t (TN)
Respbid
Respicur
Respid
S1621_Selleck
SAM002554935
SMP1_000291
SMR000058537
SPBio_000823
SPBio_002640
SPBio_002866
SPECTRUM1500568
ST024762
STK397040
Slo Phyllin
Slo-Bid
Slo-Phyllin
Slo-bid
Slo-phyllin
SloPhyllin
Solosin
Somophyllin CRT
Somophyllin T
Somophyllin-CRT
Somophyllin-Crt
Somophyllin-DF
Somophyllin-T
Somophyllin-t
SomophyllinT
Spectrum2_000842
Spectrum3_000672
Spectrum4_000353
Spectrum5_001232
Spectrum_001038
Spophyllin retard
Sustaire
Synophylate
Synophylate-L.A. Cenules
T-Phyl
T0179
T1633_SIGMA
T4924_SIGMA
T7770_SIGMA
T9031_SIGMA
THEOBID JR
Talotren
Tefamin
Telb-DS
Telbans Dry Syrup
Teocen 200
Teofilina
Teofilina [Polish]
Teofyllamin
Teolair
Teonova
Teosona
Tesona
Theacitin
Theal tabl.
Theal tablets
Theo 24
Theo Dur
Theo-11
Theo-24
Theo-24 (TN)
Theo-DS
Theo-Dur
Theo-Dur-Sprinkle
Theo-Nite
Theo-Organidin
Theo-Sav
Theo-dur
Theo24
Theobid
Theobid Duracap
Theobid Jr.
Theochron
Theocin
Theoclair-SR
Theoclear
Theoclear 80
Theoclear L.A.-130
Theoclear LA
Theoclear-200
Theoclear-80
Theocontin
Theodel
Theodrip
Theodur
Theodur Dry Syrup
Theodur G
Theodur G (TN)
Theofol
Theograd
Theokin
Theolair
Theolair (TN)
Theolair-SR
Theolair-Sr
Theolix
Theolixir
Theona P
Theonite
Theopek
Theophyl
Theophyl-225
Theophyl-SR
Theophyl-Sr
Theophyline
Theophyllin
Theophylline (JP15)
Theophylline anhydrous
Theophylline, anhydrous
Theophylline-SR
Theophylline-Sr
Theophylline-[8-3H
Theoplus
Theospan
Theostat
Theostat 80
Theotard
Theovent
UNII-0I55128JYK
UPCMLD-DP123
UPCMLD-DP123:001
Uni-Dur
Unifyl
Unilong
Uniphyl
Uniphyl (TN)
Uniphyllin
Uniphyllin continus
Uniphylline
X 115
Xanthium
Xantivent
ZINC18043251
aminophylline
ct, theo von
nchembio.273-comp2
theo von ct
theophylline
von ct, theo
4
BudesonideapprovedPhase 442251333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide MMX
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
Horacort
 
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
5
Amikacinapproved, vet_approvedPhase 4, Phase 1, Phase 26137517-28-537768
Synonyms:
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-4-(6-amino-6-deoxy-alpha-D-glucopyranosyloxy)-3-hydroxycyclohexyl]-2-hydroxybutanamide
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
(2S)-4-amino-N-{(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-4-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide
1-N-(L(-)-gamma-Amino-alpha-hydroxybutyryl)kanamycin A
1-N-(L(-)-gamma-amino-alpha-Hydroxybutyryl)kanamycin a
108914-65-4
110660-81-6
110660-83-8
111319-93-8
37517-28-5
38859-32-4
AB00513828
AC1L1YE8
AC1Q5JTM
AMIKACIN SULFATE
ANTIBIOTIC BB-K8
Amicacin
Amiglyde-V
Amiglyde-v
Amikacin
Amikacin & Tumor Necrosis Factor
Amikacin (USP)
Amikacin (USP/INN)
Amikacin Base
Amikacin Dihydrate
Amikacin Sulfate
Amikacin [USAN:BAN:INN]
Amikacina
Amikacina [INN-Spanish]
Amikacine
Amikacine [INN-French]
Amikacinum
Amikacinum [INN-Latin]
Amikavet
 
Amikin
Amikin (Disulfate)
Antibiotic BB-K 8
Arikace
BB-K 8
BB-K8
BPBio1_000671
BSPBio_000609
Briclin
C06820
C22H43N5O13
CHEBI:2637
CHEMBL177
CID37768
D02543
DB00479
EINECS 253-538-5
HSDB 3583
Kaminax
LS-146896
Lukadin
Mikavir
MolPort-000-761-900
NCGC00093350-02
NCGC00093350-03
NSC 177001
NSC177001
O-3-Amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1->4)]-1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-6))-N(sup 3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
O-3-amino-3-Deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
Prestwick3_000395
STK039706
UNII-84319SGC3C
amikacin
amikacine
6
Amoxicillinapproved, vet_approvedPhase 444126787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-╬▒-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
BRL-2333
BSPBio_000453
 
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
alpha-amino-P-Hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
╬▒-amino-p-hydroxybenzylpenicillin
7
Meropenemapproved, investigationalPhase 488119478-56-764778, 441130
Synonyms:
(1R,5S,6S)-2-[(3S,5S)-5-(dimethylaminocarbonyl)pyrrolidin-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid trihydrate
(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid
(2S,3R,4R)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-{[(3S,5R)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid
(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5S,6S)-3-((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-ylthio)-6-((S)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(6S)-2-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-1beta-methyl-2,3-didehydro-1-carbapenam-3-carboxylic acid
96036-03-2
AB00514051
AB1004614
AC1L9ALL
Ambap119478-56-7
Antibiotic SM 7338
Antibiotic sm 7338
BIDD:GT0851
BPBio1_001334
BSPBio_001212
CHEBI:43968
CHEMBL127
CID441130
CPD000469184
D08185
HMS1571M14
HMS2051G08
HMS2090C05
 
ICI-194660
MEPM
MERONEM
MLS001401437
Meronem (TN)
Meropen
Meropenem
Meropenem (INN)
Meropenem Hydrate
Meropenem anhydrous
Meropenem trihydrate
Meropenemum
Meropenemum [INN-Latin]
Meropenemum trihydricum
Merrem
Merrem I.V. (TN)
MolPort-006-709-417
NCGC00179259-01
Prestwick0_001106
Prestwick1_001106
Prestwick2_001106
Prestwick3_001106
SAM001246650
SM-7338
SMR000469184
SPBio_003086
8
AcetylcysteineapprovedPhase 4316616-91-112035
Synonyms:
(2R)-2-acetylamino-3-Sulfanylpropanoic acid
(R)-2-acetylamino-3-Mercaptopropanoic acid
(R)-Mercapturic acid
2-Acetylamino-3-mercapto-propionate
2-Acetylamino-3-mercapto-propionic acid
ACC
Acetadote
Acetilcisteina
Acetylcysteine
Acetylcysteinum
Fluimicil Infantil
Fluimucetin
Fluimucil
Flumucetin
 
Fluprowit
L-Acetylcysteine
L-alpha-acetamido-beta-Mercaptopropionic acid
Lysox
Mercapturic acid
Mucolysin
Mucomyst
N-ACETYL-L-cysteine
N-Acety-L-Cysteine
N-Acetyl-3-mercaptoalanine
N-Acetyl-L-(+)-cysteine
N-Acetylcysteine
N-acetylcysteine
NAC
Parvolex
Sodium 2-acetamido-3-mercaptopropionate
9
Cholecalciferolapproved, nutraceuticalPhase 485167-97-06221, 10883523, 5280795
Synonyms:
()-Vitamin D3
(+)-Vitamin D3
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol
47763_SUPELCO
57651-82-8
67-97-0
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
9,10-Secocholesta-5,7,10(19)-trien-3-ol
9,10-Secocholesta-5,7,10-trien-3-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
Activated 7-dehydrocholesterol
Arachitol
BPBio1_000460
BSPBio_000418
BSPBio_002408
Bio-0845
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
CID7067440
CID7251172
CID7251174
CID9821465
Calciol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol D3
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferolum
 
Colecalciferol
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Devaron
DivK1c_006276
Duphafral D3 1000
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
Ebivit
FeraCol
Granuvit D3
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC-375571
NSC375571
Oleovitamin D3
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Prestwick_63
Provitamine
Provitina
Quintox
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SR-05000001559
SR-05000001559-3
ST057172
SpecPlus_000180
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
Spectrum_001163
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
VITAMIN D
VITAMIN D3 POWDER
VITAMIN_D3
Vi-De3
Vi-de-3-hydrosol
VidDe-3-hydrosol
Videkhol
Vigantol
Vigorsan
Vitamin D3
Vitamin D3 emulsifiable
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
bmse000507
calciol
cholecalciferol
delta-D
vitamin d-3
10
Ergocalciferolapproved, nutraceuticalPhase 4123250-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
11Respiratory System AgentsPhase 4, Phase 24818
12Peripheral Nervous System AgentsPhase 4, Phase 222776
13Anti-Bacterial AgentsPhase 4, Phase 3, Phase 2, Phase 110884
14Antibiotics, AntitubercularPhase 4, Phase 3, Phase 26972
15Vasodilator AgentsPhase 43438
16Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 121402
17AntioxidantsPhase 42928
18Neurotransmitter AgentsPhase 417734
19Protective AgentsPhase 4, Phase 17190
20ImmunoglobulinsPhase 4, Phase 36045
21Anti-Asthmatic AgentsPhase 4, Phase 23369
22Bronchodilator AgentsPhase 4, Phase 22856
23Autonomic AgentsPhase 4, Phase 29774
24AntibodiesPhase 4, Phase 36045
25VaccinesPhase 4, Phase 36428
26GentamicinsPhase 4137
27Hydroxymethylglutaryl-CoA Reductase InhibitorsPhase 41956
28AntidotesPhase 4, Phase 11038
29Lipid Regulating AgentsPhase 42702
30Calcium, DietaryPhase 45525
31Budesonide, Formoterol Fumarate Drug CombinationPhase 4166
32Pharmaceutical SolutionsPhase 4, Phase 3, Phase 2, Phase 17793
33ExpectorantsPhase 4, Phase 2388
34Heptavalent Pneumococcal Conjugate VaccinePhase 4, Phase 3454
35Hypolipidemic AgentsPhase 42721
36HormonesPhase 413979
37Dermatologic AgentsPhase 4, Phase 25674
38Anti-Inflammatory AgentsPhase 4, Phase 210355
39Anti-Allergic AgentsPhase 4, Phase 21490
40
FluticasonePhase 4, Phase 263090566-53-3, 80474-14-262924, 22833648
Synonyms:
90566-53-3
AC-456
AC1NSJZT
Asmatil
Axotide
BIDD:GT0819
Brethal
C07815
CHEMBL1201396
CID5311101
Cultivate
Cutivate
D07981
Flixonase
Flixonase Nasal Spray
Flixotide
Flixotide Disk
 
Flixotide Disks
Flixotide Inhaler
Flonase
Flovent
Flovent Diskus
Flovent Rotadisk
Fluinol
Flunase
Flusonal
Fluspiral
Fluticaps
Fluticaps (TN)
Fluticasone (INN)
Fluticasonpropionat Allen
Flutide
Flutivate
MolPort-006-666-449
S-(fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate
fluticasone
41Hormone AntagonistsPhase 412778
42Fluticasone Propionate, Salmeterol Xinafoate Drug CombinationPhase 4201
43glucocorticoidsPhase 44920
44Atorvastatin CalciumPhase 4743134523-03-8
45Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 412767
46Adrenergic beta-AgonistsPhase 41640
47Anticholesteremic AgentsPhase 41983
48AntimetabolitesPhase 411774
49Adrenergic AgentsPhase 45140
50Adrenergic AgonistsPhase 42877

Interventional clinical trials:

(show top 50)    (show all 200)
idNameStatusNCT IDPhase
1A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With BronchiectasisUnknown statusNCT01677403Phase 4
2Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis BronchiectasisCompletedNCT02782312Phase 4
3Is Regular Chest Physiotherapy an Effective Treatment in Severe, Non Cystic Fibrosis Bronchiectasis?CompletedNCT00816309Phase 4
4The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of BronchiectasisCompletedNCT01769898Phase 4
5Efficacy of Azithromycin in Treatment of BronchiectasisCompletedNCT02107274Phase 4
6The Effect of Theophylline in the Treatment of BronchiectasisCompletedNCT01684683Phase 4
7Pulmonary Rehabilitation in Non Cystic Fibrosis BronchiectasisCompletedNCT00868075Phase 4
8A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis BronchiectasisCompletedNCT01299181Phase 4
9Long Term Nebulised Gentamicin in Patients With BronchiectasisCompletedNCT00749866Phase 4
10Effectiveness and Safety of Inhaling Hypertonic Saline in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00639236Phase 4
11Efficacy of Temporary Positive Expiratory Pressure (TPEP) in Chronic HypersecretionCompletedNCT00700388Phase 4
12Bacterial Load Guided Therapy for Severe Bronchiectasis ExacerbationsRecruitingNCT02047773Phase 4
13Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis BronchiectasisRecruitingNCT02507843Phase 4
14Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of BronchiectasisRecruitingNCT02509091Phase 4
15Comparisons of Inhaled LAMA or ICS+LABA for COPD With BronchiectasisRecruitingNCT02546297Phase 4
16Hospitalised Pneumonia With Extended Treatment (HOPE) StudyRecruitingNCT02783859Phase 4
17Polysaccharide Antibody Response StudyRecruitingNCT02429531Phase 4
18Atorvastatin in Bronchiectasis in Patients With Pseudomonas AeruginosaActive, not recruitingNCT01299194Phase 4
19Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis BronchiectasisActive, not recruitingNCT02081963Phase 4
20Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of BronchiectaisisActive, not recruitingNCT02088216Phase 4
21Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)Active, not recruitingNCT01830959Phase 4
22Oscillating PEP vs Autogenic Drainage in People With BronchiectasisNot yet recruitingNCT03013452Phase 4
23Bronchiectasis and Long Term Azithromycin TreatmentUnknown statusNCT00415350Phase 3
24The Role of Inhalations of Tranexamic Acid in Patients With HemoptysisUnknown statusNCT01496196Phase 3
25Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF BronchiectasisCompletedNCT02104245Phase 3
26Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)CompletedNCT01764841Phase 3
27Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)CompletedNCT02106832Phase 3
28Inhaled Mannitol as a Mucoactive Therapy for BronchiectasisCompletedNCT00669331Phase 3
29Safety and Efficacy of Bronchitol in BronchiectasisCompletedNCT00277537Phase 3
30The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis BronchiectasisCompletedNCT00484263Phase 3
31Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis BronchiectasisCompletedNCT01313624Phase 3
32Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis BronchiectasisCompletedNCT01314716Phase 3
33Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF BronchiectasisCompletedNCT01515007Phase 3
34Efficacy and Safety Study of a Percussion Device to Mobilise Sputum From Respiratory PassageCompletedNCT01480882Phase 2, Phase 3
35Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)CompletedNCT00656409Phase 3
36EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft RejectionCompletedNCT00105183Phase 3
37Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of AG1321001 in Chronic CougherCompletedNCT00380315Phase 3
38Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CFCompletedNCT01641822Phase 3
39Prevention of OM-85 on Bronchiectasis ExacerbationRecruitingNCT01968421Phase 3
40Prevention of Bronchiectasis in Infants With Cystic FibrosisRecruitingNCT01270074Phase 3
41An Open Label Trial of Azithromycin in Chronic Productive CoughRecruitingNCT02196493Phase 3
42Effects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalizationRecruitingNCT01973998Phase 3
43The Efficacy of Azithromycin in Treating Children With Non Cystic Fibrosis BronchiectasisActive, not recruitingNCT02531984Phase 3
44Inhaled Nebulized Tobramycin in Non-cystic Fibrosis BronchiectasisEnrolling by invitationNCT02657473Phase 2, Phase 3
45Hypertonic Saline (6%) Versus Isotonic Saline (0.9%) in BronchiectasisUnknown statusNCT01112410Phase 2
46Phase2, Single Group, Open Clinical Trial to Evaluate the Efficacy and Safety of Roflumilast in Symptomatic Bronchiectasis PatientsUnknown statusNCT01580748Phase 2
47Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis BronchiectasisCompletedNCT02035488Phase 1, Phase 2
48Physical Capacity in Patients With Bronchiectasis Before and After Rehabilitation ProgramCompletedNCT02208830Phase 1, Phase 2
49A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With BronchiectasisCompletedNCT00769119Phase 2
50Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With BronchiectasisCompletedNCT00805025Phase 2

Search NIH Clinical Center for Bronchiectasis

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: bronchiectasis

Genetic Tests for Bronchiectasis

About this section

Anatomical Context for Bronchiectasis

About this section

MalaCards organs/tissues related to Bronchiectasis:

36
Lung, Neutrophil, Heart, Testes, Colon, Bone, Thyroid

Publications for Bronchiectasis

About this section

Articles related to Bronchiectasis:

(show top 50)    (show all 760)
idTitleAuthorsYear
1
Sugar coating bronchiectasis. (28070016)
2017
2
Two cases of non-cystic fibrosis (CF) bronchiectasis with allergic bronchopulmonary aspergillosis. (28053855)
2017
3
Microbial Dysbiosis in Bronchiectasis and Cystic Fibrosis. (28069292)
2017
4
Diffuse bronchiectasis as the primary manifestation of endobronchial sarcoidosis. (27896060)
2017
5
Comparing accelerometer, pedometer and a questionnaire for measuring physical activity in bronchiectasis: a validity and feasibility study? (28088206)
2017
6
Assessment of the quantity of microorganisms associated with bronchiectasis in saliva, sputum and nasal lavage after periodontal treatment: a study protocol of a randomised controlled trial. (27084279)
2016
7
High prevalence of bronchiectasis in patients with cartilage-hair hypoplasia. (27568079)
2016
8
Asthma and bronchiectasis exacerbation. (27076584)
2016
9
Importance of fractional exhaled nitric oxide in diagnosis of bronchiectasis accompanied with bronchial asthma. (27162676)
2016
10
Macrolides for Clinically Significant Bronchiectasis in Adults: Who Should Receive this Treatment? (27591924)
2016
11
In Reply: Towards precision medicine: phenotyping bronchiectasis with unsupervised learning technique. (27084831)
2016
12
Clinical phenotypes in bronchiectasis: right on track to develop precision medicine in respiratory diseases. (27084830)
2016
13
Neutrophil Fates in Bronchiectasis and Alpha-1 Antitrypsin Deficiency. (27115946)
2016
14
Evaluation of a novel information resource for patients with bronchiectasis: study protocol for a randomised controlled trial. (27107959)
2016
15
Risk factors for requiring intravenous antibiotic therapy in hospital and 30-day readmission for exacerbations of bronchiectasis. (27081209)
2016
16
Quantitative CT measures of bronchiectasis in smokers. (27890712)
2016
17
Left middle lobectomy for bronchiectasis in a patient with Kartagener syndrome: a case report. (26960394)
2016
18
Quality standards for the management of bronchiectasis in Italy: a national audit. (27076581)
2016
19
Bronchiectasis in 2016: advances in our understanding. (27890499)
2016
20
Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts. (27516225)
2016
21
IMAGING DIAGNOSIS-COMPUTED TOMOGRAPHY OF TRACTION BRONCHIECTASIS SECONDARY TO PULMONARY FIBROSIS IN A PATTERDALE TERRIER. (27490688)
2016
22
Factors related to depression and anxiety in adults with bronchiectasis. (27920537)
2016
23
Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. (27492530)
2016
24
Telomere Dysfunction and Senescence-associated Pathways in Bronchiectasis. (27082536)
2016
25
Impulse Oscillometry and Spirometry Small-Airway Parameters in Mild to Moderate Bronchiectasis. (27484107)
2016
26
Prevalence of Osteopenia and Osteoporosis in Patients with Noncystic Fibrosis Bronchiectasis. (27911973)
2016
27
ERJ September Podcast: research priorities in bronchiectasis. (27581418)
2016
28
Phenotyping bronchiectasis: is it all about sputum and infection? (27037310)
2016
29
Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: Implications and Future Research. (27569224)
2016
30
The development of bronchiectasis on chest computed tomography in children with cystic fibrosis: can pre-stages be identified? (27108295)
2016
31
Enlarged Dural Sac in Idiopathic Bronchiectasis Implicates Heritable Connective Tissue Gene Variants. (27409985)
2016
32
Annual direct medical costs of bronchiectasis treatment: Impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistence. (27072020)
2016
33
Recommendations for aetiological diagnosis of bronchiectasis. (27134122)
2016
34
Genesis of the Nodular Bronchiectasis Phenotype of Pulmonary Disease Due to Nontuberculous Mycobacteria. (27055711)
2016
35
Virulence Adaptations of Pseudomonas aeruginosa Isolated from Patients with Non-Cystic Fibrosis Bronchiectasis. (27902425)
2016
36
Bronchiectasis in the Last Five Years: New Developments. (27941638)
2016
37
FUT2 genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis. (27503233)
2016
38
Tracheobronchomegaly as a Cause of Bronchiectasis in an Adult. (27022496)
2016
39
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. (27864036)
2016
40
Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review. (27507832)
2016
41
Surgery for predominant lesion in nonlocalized bronchiectasis. (28073573)
2016
42
Video-assisted thoracoscopic segmentectomy of lingual segment of the left upper pulmonary lobe for chronic focal bronchiectasis. (27076962)
2016
43
Prevalence and incidence of bronchiectasis in Catalonia, Spain: A population-based study. (27888988)
2016
44
Time Trends in Hospital Admissions for Bronchiectasis: Analysis of the Spanish National Hospital Discharge Data (2004 to 2013). (27622273)
2016
45
Adult Bronchiectasis Patients: A First Look at the United States Bronchiectasis Research Registry. (27889361)
2016
46
Unusual cause of localised bronchiectasis. (27516226)
2016
47
Primary ciliary dyskinesia in six patients with bronchiectasis. (27238169)
2016
48
Lung transplantation for non-cystic fibrosis bronchiectasis. (27215505)
2016
49
Cystic Bronchiectasis Imitating Pulmonary Aspergilloma. (27569246)
2016
50
Unsupervised learning technique identifies bronchiectasis phenotypes with distinct clinical characteristics. (27046724)
2016

Variations for Bronchiectasis

About this section

Clinvar genetic disease variations for Bronchiectasis:

5 (show all 61)
id Gene Variation Type Significance SNP ID Assembly Location
1CCNONM_021147.4(CCNO): c.248_252dupTGCCC (p.Gly85Cysfs)duplicationPathogenicrs587777498GRCh38Chr 5, 55233272: 55233276
2CCNONM_021147.4(CCNO): c.258_262dupGGCCC (p.Gln88Argfs)duplicationPathogenicrs587777499GRCh38Chr 5, 55233262: 55233266
3CCNONM_021147.4(CCNO): c.926delC (p.Pro309Argfs)deletionPathogenicrs587777500GRCh38Chr 5, 55231502: 55231502
4CCNONM_021147.4(CCNO): c.961C> T (p.Gln321Ter)SNVPathogenicrs587777501GRCh38Chr 5, 55231467: 55231467
5CCNONM_021147.4(CCNO): c.263_267dupAGCCC (p.Val90Serfs)duplicationPathogenicrs587777502GRCh38Chr 5, 55233257: 55233261
6CCNONM_021147.4(CCNO): c.481_482delCT (p.Leu161Glyfs)deletionPathogenicrs587777503GRCh38Chr 5, 55232446: 55232447
7CCDC151NM_145045.4(CCDC151): c.925G> T (p.Glu309Ter)SNVPathogenicrs587777779GRCh38Chr 19, 11426182: 11426182
8CCDC151NM_145045.4(CCDC151): c.1256C> A (p.Ser419Ter)SNVPathogenicrs587777780GRCh37Chr 19, 11533390: 11533390
9DNAH8NM_001206927.1(DNAH8): c.2419C> T (p.Arg807Ter)SNVPathogenicrs567050969GRCh38Chr 6, 38786788: 38786788
10DNAAF2NM_018139.2(DNAAF2): c.1199_1214dupACGATACCTGCGTGGC (p.Gly406Argfs)duplicationPathogenicrs397515341GRCh38Chr 14, 49633936: 49633951
11DNAH5NM_001369.2(DNAH5): c.4348C> T (p.Gln1450Ter)SNVPathogenicrs771663107GRCh37Chr 5, 13865784: 13865784
12DNAAF2NM_018139.2(DNAAF2): c.31delG (p.Glu11Argfs)deletionPathogenicrs797045146GRCh38Chr 14, 49635119: 49635119
13RSPH4ANM_001010892.2(RSPH4A): c.166dupC (p.Arg56Profs)duplicationPathogenicrs797045147GRCh37Chr 6, 116937952: 116937952
14LRRC6NM_012472.5(LRRC6): c.630delG (p.Trp210Cysfs)deletionPathogenicrs760123202GRCh37Chr 8, 133645009: 133645009
15ARMC4NM_018076.4(ARMC4): c.1669G> T (p.Glu557Ter)SNVPathogenicrs145742175GRCh37Chr 10, 28233225: 28233225
16RSPH1NM_080860.3(RSPH1): c.366G> A (p.Arg122=)SNVPathogenicrs797045148GRCh37Chr 21, 43905914: 43905914
17RSPH1NM_080860.3(RSPH1): c.727+5G> A (p.Ala244ValfsTer22)SNVPathogenicrs200382776GRCh37Chr 21, 43897396: 43897396
18SPAG1NM_172218.2(SPAG1): c.902_906delAAGTA (p.Lys301Thrfs)deletionPathogenicrs797045149GRCh37Chr 8, 101203687: 101203691
19C21orf59NM_021254.2(C21orf59): c.735C> G (p.Tyr245Ter)SNVPathogenicrs202094637GRCh38Chr 21, 32602299: 32602299
20CCDC65NP_149115.2: p.Ile293ProfsTer2deletionPathogenicChr na, -1: -1
21CCNONM_021147.4(CCNO): c.716A> G (p.His239Arg)SNVPathogenicrs797045150GRCh37Chr 5, 54527540: 54527540
22DNAH1NM_015512.4(DNAH1): c.3460A> C (p.Lys1154Gln)SNVPathogenicrs544674332GRCh37Chr 3, 52387629: 52387629
23MCIDASNM_001190787.1(MCIDAS): c.441C> A (p.Cys147Ter)SNVPathogenicrs777031813GRCh37Chr 5, 54518169: 54518169
24MCIDASNM_001190787.1(MCIDAS): c.1097G> A (p.Gly366Asp)SNVPathogenicrs797045151GRCh37Chr 5, 54516255: 54516255
25MCIDASNM_001190787.1(MCIDAS): c.1142G> A (p.Arg381His)SNVPathogenicrs797045152GRCh37Chr 5, 54516210: 54516210
26RSPH3NM_031924.4(RSPH3): c.631-2A> GSNVPathogenicrs142800871GRCh37Chr 6, 159407455: 159407455
27DNAAF1NM_178452.5(DNAAF1): c.1349dupC (p.Pro451Alafs)duplicationPathogenicrs397515339GRCh37Chr 16, 84203783: 84203783
28DNAAF1NM_178452.5(DNAAF1): c.524T> G (p.Leu175Arg)SNVPathogenicrs267607227GRCh37Chr 16, 84188353: 84188353
29DNAL1NM_031427.3(DNAL1): c.449A> G (p.Asn150Ser)SNVPathogenicrs387907021GRCh37Chr 14, 74156135: 74156135
30DNAAF3NM_001256714.1(DNAAF3): c.386T> C (p.Leu129Pro)SNVPathogenicrs387907151GRCh37Chr 19, 55677272: 55677272
31DNAAF3NM_001256714.1(DNAAF3): c.469C> T (p.Arg157Ter)SNVPathogenicrs387907152GRCh37Chr 19, 55676795: 55676795
32DNAAF3NM_001256714.1(DNAAF3): c.825dupT (p.Val276Cysfs)duplicationPathogenicrs397515395GRCh37Chr 19, 55673053: 55673053
33CCDC103NM_213607.2(CCDC103): c.383dupG (p.Pro129Serfs)duplicationPathogenicrs587776910GRCh37Chr 17, 42979839: 42979839
34CCDC103NM_213607.2(CCDC103): c.461A> C (p.His154Pro)SNVPathogenicrs145457535GRCh37Chr 17, 42979917: 42979917
35CCDC114NM_144577.3(CCDC114): c.742G> A (p.Ala248Thr)SNVPathogenicrs147718607GRCh37Chr 19, 48807210: 48807210
36HYDINNM_001270974.2(HYDIN): c.3985G> T (p.Val1329Leu)SNVPathogenicrs397515413GRCh37Chr 16, 71022036: 71022036
37HYDINNM_001270974.2(HYDIN): c.922A> T (p.Lys308Ter)SNVPathogenicrs397515414GRCh37Chr 16, 71171175: 71171175
38DNAI2NM_023036.4(DNAI2): c.346-3T> G (p.Ile116GlyfsTer54)SNVPathogenicrs397515358GRCh37Chr 17, 72283113: 72283113
39DNAAF2NM_018139.2(DNAAF2): c.23C> A (p.Ser8Ter)SNVPathogenicrs137853191GRCh37Chr 14, 50101845: 50101845
40DRC1NM_145038.4(DRC1): c.2056A> T (p.Lys686Ter)SNVPathogenicrs587776997GRCh37Chr 2, 26677651: 26677651
41DRC1NM_145038.4(DRC1): c.352C> T (p.Gln118Ter)SNVLikely pathogenic, Pathogenicrs142371860GRCh37Chr 2, 26644264: 26644264
42DNAI1NM_012144.3(DNAI1): c.48+2dupT (p.Ser17ValfsTer12)duplicationPathogenicrs397515363GRCh37Chr 9, 34459053: 34459053
43DNAI1NM_012144.3(DNAI1): c.282_283insAATA (p.Gly95Asnfs)insertionPathogenicrs606231164GRCh38Chr 9, 34489343: 34489344
44DNAI1NM_012144.3(DNAI1): c.1543G> A (p.Gly515Ser)SNVPathogenicrs79833450GRCh37Chr 9, 34513163: 34513163
45DNAI1NM_012144.3(DNAI1): c.1658_1669delCCAAGGTCTTCA (p.Thr553_Phe556del)deletionPathogenicrs606231165GRCh38Chr 9, 34514482: 34514493
46DNAI1NM_012144.3(DNAI1): c.1490G> A (p.Gly497Asp)SNVPathogenicrs376252276GRCh37Chr 9, 34513110: 34513110
47DNAI1NM_012144.3(DNAI1): c.2001+1G> A (p.Ala607_Lys667del)SNVPathogenicrs397515563GRCh37Chr 9, 34517466: 34517466
48DNAI2NM_023036.4(DNAI2): c.1494+1G> C (p.Val450_Ser498del)SNVPathogenicrs397515565GRCh37Chr 17, 72306303: 72306303
49ZMYND10NM_015896.3(ZMYND10): c.47T> G (p.Val16Gly)SNVPathogenicrs138815960GRCh37Chr 3, 50382964: 50382964
50ZMYND10NM_015896.3(ZMYND10): c.797T> C (p.Leu266Pro)SNVPathogenicrs200913791GRCh37Chr 3, 50379904: 50379904
51ARMC4NM_018076.4(ARMC4): c.2780T> G (p.Leu927Trp)SNVPathogenicrs587777047GRCh37Chr 10, 28151382: 28151382
52RSPH1NM_080860.3(RSPH1): c.85G> T (p.Glu29Ter)SNVPathogenicrs138320978GRCh37Chr 21, 43913159: 43913159
53RSPH1NM_080860.3(RSPH1): c.366-3C> ASNVPathogenicrs587777058GRCh37Chr 21, 43905917: 43905917
54RSPH1NM_080860.3(RSPH1): c.407_410delAGTA (p.Lys136Metfs)deletionPathogenicrs587777059GRCh37Chr 21, 43905870: 43905873
55RSPH1NM_080860.3(RSPH1): c.275-2A> C (p.Gly92AlafsTer10)SNVPathogenicrs151107532GRCh37Chr 21, 43906573: 43906573
56RSPH9NM_152732.4(RSPH9): c.804_806delGAA (p.Lys268del)deletionPathogenicrs397515340GRCh37Chr 6, 43638659: 43638661
57SPAG1NC_000008.11: g.100151617_100163589del11973deletionPathogenicGRCh38Chr 8, 100151617: 100163589
58SPAG1NM_172218.2(SPAG1): c.2014C> T (p.Gln672Ter)SNVPathogenicrs201740530GRCh37Chr 8, 101245664: 101245664
59C21orf59NM_021254.2(C21orf59): c.292C> T (p.Arg98Ter)SNVPathogenicrs143740376GRCh37Chr 21, 33982163: 33982163
60C21orf59NM_021254.2(C21orf59): c.792_795delTTTA (p.Tyr264Terfs)deletionPathogenicrs398122401GRCh37Chr 21, 33974251: 33974254
61RSPH4ANM_001010892.2(RSPH4A): c.921+3_921+6delAAGT (p.Tyr230GlnfsTer8)deletionPathogenicrs869320683GRCh37Chr 6, 116944168: 116944171

Expression for genes affiliated with Bronchiectasis

About this section
Search GEO for disease gene expression data for Bronchiectasis.

Pathways for genes affiliated with Bronchiectasis

About this section

GO Terms for genes affiliated with Bronchiectasis

About this section

Cellular components related to Bronchiectasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1axonemal dynein complexGO:000585811.2DNAH5, DNAI2
2ciliumGO:000592911.2CCDC114, DNAI1, LRRC6
3axonemeGO:000593011.0ARMC4, CCDC103, CCDC114, DNAH5, DNAI2, DRC1
4cytoskeletonGO:000585610.9ARMC4, DNAI1, DRC1, RSPH4A, RSPH9
5motile ciliumGO:003151410.7CCDC103, RSPH1, RSPH4A, RSPH9
6outer dynein armGO:003615710.7CCDC114, DNAH5, DNAI1, DNAI2
7cytoplasmGO:000573710.6ARMC4, CCDC103, CCNO, DNAAF2, DNAAF3, DNAH5
8sperm flagellumGO:003612610.4DNAI2, RSPH1

Biological processes related to Bronchiectasis according to GeneCards Suite gene sharing:

(show all 13)
idNameGO IDScoreTop Affiliating Genes
1bacterial-type flagellum-dependent cell motilityGO:007197311.1DNAAF2, DRC1
2axoneme assemblyGO:003508211.0RSPH1, RSPH4A, RSPH9
3cilium-dependent cell motilityGO:006028511.0DNAAF2, DRC1
4cilium assemblyGO:006027111.0CCNO, DNAH5, DNAI2
5epithelial cilium movement involved in determination of left/right asymmetryGO:006028711.0CCDC103, LRRC6
6determination of left/right symmetryGO:000736810.9ARMC4, DNAH5, DNAI1, DNAI2, DRC1
7axonemal dynein complex assemblyGO:007028610.9CCDC103, DNAAF2, DNAAF3, DRC1, SPAG1
8heart developmentGO:000750710.8ARMC4, DNAH5, DNAI1, DRC1
9cilium movementGO:000334110.8ARMC4, CCDC103, CCDC114, DNAH5, DNAI1, DNAI2
10inner dynein arm assemblyGO:003615910.8CCDC103, LRRC6, ZMYND10
11motile cilium assemblyGO:004445810.6DNAAF3, LRRC6, RSPH9, ZMYND10
12sperm motilityGO:009772210.4DNAH5, DNAI1, LRRC6
13outer dynein arm assemblyGO:003615810.1ARMC4, CCDC103, CCDC114, DNAH5, DNAI1, DNAI2

Sources for Bronchiectasis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet